Center for Biologics Evaluation and Research (CBER): COVID-19
🏛 Food and Drug Administration (FDA)FDA-2020-D-1137
Documents
1
Total comments
20
2 awaiting analysis
Comment status
Open
Last activity
Aug 28, 2025
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherOct 20, 2023
Development and Licensure of Vaccines to Prevent COVID-19 Guidance for IndustryNo comment period💬 20 comments · 2 awaiting analysis